Exsurgo is proud to work with Homeless Shelter Micah House in Nebraska
Exsurgo is proud to work with Homeless Shelter Micah House in Nebraska Read more…
Exsurgo is proud to work with Homeless Shelter Micah House in Nebraska Read More »
Exsurgo is proud to work with Homeless Shelter Micah House in Nebraska Read more…
Exsurgo is proud to work with Homeless Shelter Micah House in Nebraska Read More »
With the tech scene currently booming in New Zealand, and with more and more innovative companies coming up every week, local creative business outlet, Idealog has outlined some of the companies they will be keeping an eye out on in 2023 including our very own Exsurgo. From financial ventures to breakthroughs in the health industry,
Tech companies to look out for in 2023 Read More »
Exsurgo has launched new study using EEG neurofeedback as a therapy to manage neuropathic pain in the United Kingdom. Funded by Exsurgo, the new trial is being led by researchers from the East Kent Hospitals University NHS Foundation Trust. Researchers are currently recruiting for ten patients who, over a 22 week period, will wear an
East Kent chronic pain management medical trial launches in the UK Read More »
How gamification can support treatment for chronic pain and other neurological conditions Whether it’s smoking, drinking, eating unhealthy food or even mindlessly scrolling through social media, people can’t resist a quick hit of pleasure despite knowing the long-term pitfalls of such behaviour. Through a healthcare lens, this can be dangerous because many of us make
When a game is more than play Read More »
Hi all, We are thrilled to share that our final trialist has completed the Active Neurofeedback Treatment phase of the New Zealand Axon trial in partnership with Auckland University of Technology (AUT) and Waitematā District Health Board (WDHB). As a random Controlled Clinical Trial, it is considered the ‘gold standard’ of clinical trials. The trial
Exsurgo’s Mindpower Newsletter – November 2022 Read More »
This article first appeared in NZBusiness Magazine. Richard Little is an inventor making traction in the treatment of chronic pain and other neurological conditions without the use of pharmaceuticals. Here he shares his lessons and advice for health tech entrepreneurs. Entrepreneurship is not a career path known for stable and steady progression. From crying in
Confessions of a health tech entrepreneur Read More »
Our CEO and Co-founder Richard Little recently featured in the first of a three-part series by NBR’s Fiona Rotherham on the current challenges facing New Zealand’s healthtech sector. The key challenge facing the sector is the need for a national network of innovation hubs to help early-stage companies with funding, commercialisation, and research. This hub
The challenges for NZ’s booming healthtech sector Read More »
Our CEO, Richard Little, spoke with The Nutters Club’s Hamish Williams about the connection between chronic pain and mental health. As Richard explains, when we’re experiencing chronic pain it can negatively impact our sleep and lead to anxious thoughts about whether we will be able to get through our day or not. This can prevent us
The connection between chronic pain and mental health Read More »
Men and women respond to pain differently, according to new research published in the journal ‘Brain.’ Comparing how pain signals are transmitted to the brain via the spinal cord, researchers found that hormones significantly altered how women responded to pain. Exsurgo’s Chief Science Officer spoke on RadioNZ’s Nights with Bryan Crump about what this research
The gendered differences of pain Read More »
This article first appeared in Idealog. A New Zealand neuro technology company is helping chronic pain patients on their rehabilitation journey through simple games. Operating out of the North Shore suburb of Albany in Auckland, Exsurgo manufactures the Axon system – a piece of technology used to help those living with chronic pain. With one in five
Exsurgo helps Kiwis battle chronic pain with new gaming technology Read More »